Collegium Pharmaceutical (COLL) Share-based Compensation (2014 - 2026)

Collegium Pharmaceutical's Share-based Compensation history runs 13 years deep, the most recent figure standing at $10.9 million for Q1 2026.

• In Q1 2026, Share-based Compensation fell 5.59% year-over-year to $10.9 million; the TTM figure through Mar 2026 stood at $41.3 million (up 13.2% YoY), while the FY2025 annual figure was $41.9 million, up 29.34% from the prior year.
• Share-based Compensation was $10.9 million for Q1 2026 at Collegium Pharmaceutical, up from $9.8 million in the prior quarter.
• In the past five years, Share-based Compensation ranged from a high of $11.5 million in Q1 2025 to a low of $5.4 million in Q3 2022.
• Historically, Share-based Compensation has averaged $8.0 million across 5 years, with a median of $7.3 million in 2024.
• The sharpest annual moves came in 2022 and 2025: Share-based Compensation slipped 12.65% in 2022, then jumped 54.17% in 2025.
• A 5-year view of Share-based Compensation shows it stood at $5.7 million in 2022, then increased by 23.49% to $7.0 million in 2023, then climbed by 8.48% to $7.6 million in 2024, then increased by 28.4% to $9.8 million in 2025, then advanced by 11.56% to $10.9 million in 2026.
• The last three Share-based Compensation figures came in at $10.9 million (Q1 2026), $9.8 million (Q4 2025), and $9.8 million (Q3 2025), per Business Quant data.